As of 2024-05-05, the Relative Valuation of CVS Health Corp (CVS) is 108.59 USD. This relative valuation is based on P/E multiples. With the latest stock price at 55.90 USD, the upside of CVS Health Corp based on Relative Valuation is 94.3%.
The range of the Relative Valuation is 96.37 - 129.63 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 19.1x | 18.5x |
| Forward P/E multiples | 14.1x - 19.0x | 16.1x |
| Fair Price | 96.37 - 129.63 | 108.59 |
| Upside | 72.4% - 131.9% | 94.3% |
| Date | P/E |
| 2024-05-03 | 9.62 |
| 2024-05-02 | 9.50 |
| 2024-05-01 | 9.70 |
| 2024-04-30 | 11.66 |
| 2024-04-29 | 11.61 |
| 2024-04-26 | 11.57 |
| 2024-04-25 | 11.59 |
| 2024-04-24 | 11.67 |
| 2024-04-23 | 11.79 |
| 2024-04-22 | 11.99 |
| 2024-04-19 | 12.01 |
| 2024-04-18 | 11.95 |
| 2024-04-17 | 11.81 |
| 2024-04-16 | 11.89 |
| 2024-04-15 | 11.87 |
| 2024-04-12 | 11.82 |
| 2024-04-11 | 12.01 |
| 2024-04-10 | 12.25 |
| 2024-04-09 | 12.63 |
| 2024-04-08 | 12.82 |
| 2024-04-05 | 12.84 |
| 2024-04-04 | 12.72 |
| 2024-04-03 | 12.84 |
| 2024-04-02 | 12.71 |
| 2024-04-01 | 13.70 |
| 2024-03-28 | 13.73 |
| 2024-03-27 | 13.68 |
| 2024-03-26 | 13.66 |
| 2024-03-25 | 13.60 |
| 2024-03-22 | 13.51 |
| 2024-03-21 | 13.48 |
| 2024-03-20 | 13.60 |
| 2024-03-19 | 13.44 |
| 2024-03-18 | 13.36 |
| 2024-03-15 | 13.33 |
| 2024-03-14 | 13.16 |
| 2024-03-13 | 12.93 |
| 2024-03-12 | 12.95 |
| 2024-03-11 | 13.07 |
| 2024-03-08 | 12.93 |
| 2024-03-07 | 12.79 |
| 2024-03-06 | 12.80 |
| 2024-03-05 | 12.69 |
| 2024-03-04 | 12.72 |
| 2024-03-01 | 12.71 |
| 2024-02-29 | 12.80 |
| 2024-02-28 | 12.95 |
| 2024-02-27 | 13.13 |
| 2024-02-26 | 13.16 |
| 2024-02-23 | 13.29 |